Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Real-world study of 3% diquafosol ophthalmic solution in dry eye
ChiCTR2100052852Phase 4Recruiting
- Sponsor
- Xiamen Eye Center of Xiamen University
- Start
- Nov 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of diquafosol in dry eye syndrome (DED), sponsored by Xiamen Eye Center of Xiamen University. Primary endpoint: Change in fluorescein tear film break-up time from baseline. Started Nov 2021; status: recruiting.
02
Drugs
diquafosol
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on ChiCTR2100052852.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100052852.